Search
for
Sort by
Research 31–60 of 1000+
- 73571 The real-world impact of JAK inhibitor treatment on anxiety and depression outcomes and the role of eyebrow and eyelash hair regrowth in alopecia areata: TARGET-DERM
- Patient preferences for treatment characteristics of Janus kinase inhibitors for alopecia areata: a discrete choice experiment
- 75995 Social Listening Analysis of 143,000 Online Conversations on Hair Loss Treatments: Side Effects, Satisfaction, and Discontinuation
- Platelet rich plasma in androgenetic alopecia: A critical analysis of current treatment modalities
- Compare the Efficacy of PRP Intervention VS Exosomes for Hair loss, a Case Series Study
- Granuloma annulare with alopecia areata in a 6-year-old girl: a case report
- Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b–3 trial
- Two Phase 3 Trials of Baricitinib for Alopecia Areata
- A preliminary observation: Male pattern hair loss among hospitalized COVID‐19 patients in Spain – A potential clue to the role of androgens in COVID‐19 severity
- The Alopecia Areata Investigator Global Assessment scale: a measure for evaluating clinically meaningful success in clinical trials
- Efficacy and safety of the oral Janus kinase inhibitor baricitinib in the treatment of adults with alopecia areata: Phase 2 results from a randomized controlled study
- Efficacy and safety of deuruxolitinib, an oral selective Janus kinase inhibitor, in adults with alopecia areata: Results from the Phase 3 randomized, controlled trial (THRIVE-AA1)
- Topical Janus kinase inhibitors: A review of applications in dermatology
- The use of oral pioglitazone in the treatment of lichen planopilaris
- Development of Clinician-Reported Outcome (ClinRO) and Patient-Reported Outcome (PRO) Measures for Eyebrow, Eyelash and Nail Assessment in Alopecia Areata
- Comorbidities in patients with alopecia areata
- New and Emerging Therapies for Alopecia Areata
- Hair: What is New in Diagnosis and Management?
- Clinical Efficacy of Diphenylcyclopropenone in Alopecia Areata: Retrospective Data Analysis of 50 Patients
- The Invisible Impact of a Visible Disease: Psychosocial Impact of Alopecia Areata
- Complementary and Alternative Treatments for Alopecia: A Comprehensive Review
- Updates in therapeutics for folliculitis decalvans: A systematic review with evidence-based analysis
- Topical ketoconazole: a systematic review of current dermatological applications and future developments
- 5‐alpha‐reductase inhibitors are associated with reduced frequency of COVID‐19 symptoms in males with androgenetic alopecia
- Pathogenesis and treatment options for chemotherapy‐induced alopecia: a systematic review
- “‘You lose your hair, what’s the big deal?’ I was so embarrassed, I was so self-conscious, I was so depressed:” a qualitative interview study to understand the psychosocial burden of alopecia areata
- Medication-Induced Repigmentation of Gray Hair: A Systematic Review
- A Systematic Review of the Outcome of Hair Transplantation in Primary Scarring Alopecia
- Androgen receptor genetic variant predicts COVID‐19 disease severity: a prospective longitudinal study of hospitalized COVID‐19 male patients
- Alopecia and Associated Toxic Agents: A Systematic Review